-
1
-
-
0027238608
-
Clozapine-induced agranulocytosis. Incidence and risk factors in the United States
-
Alvir JM, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N Engl J Med 1993; 329: 162-7.
-
(1993)
N Engl J Med
, vol.329
, pp. 162-167
-
-
Alvir, J.M.1
Lieberman, J.A.2
Safferman, A.Z.3
Schwimmer, J.L.4
Schaaf, J.A.5
-
2
-
-
77954478688
-
Clozapine-induced agranulocytosis and use of G-CSF
-
Srinivasan TN, Thomas K. Clozapine-induced agranulocytosis and use of G-CSF. Indian J Psychiatry 1998; 40: 70-2.
-
(1998)
Indian J Psychiatry
, vol.40
, pp. 70-72
-
-
Srinivasan, T.N.1
Thomas, K.2
-
3
-
-
84884130402
-
Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis
-
Raveendranathan D, Sharma E, Venkatasubramanian G, Rao MG, Varambally S, Gangadhar BN. Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis. Gen Hosp Psychiatry 2012; 35: 574.
-
(2012)
Gen Hosp Psychiatry
, vol.35
, pp. 574
-
-
Raveendranathan, D.1
Sharma, E.2
Venkatasubramanian, G.3
Rao, M.G.4
Varambally, S.5
Gangadhar, B.N.6
-
4
-
-
0031044590
-
Mechanism of clozapineinduced agranulocytosis: Current status of research and implications for drug development
-
Pirmohamed M, Park K. Mechanism of clozapineinduced agranulocytosis: Current status of research and implications for drug development. CNS Drugs 1997; 7: 139-58.
-
(1997)
CNS Drugs
, vol.7
, pp. 139-158
-
-
Pirmohamed, M.1
Park, K.2
-
5
-
-
0033938971
-
Induction of metabolism-dependent and-independent neutrophil apoptosis by clozapine
-
Williams DP, Pirmohamed M, Naisbitt DJ, Uetrecht JP, Park BK. Induction of metabolism-dependent and-independent neutrophil apoptosis by clozapine. Mol Pharmacol 2000; 58: 207-16.
-
(2000)
Mol Pharmacol
, vol.58
, pp. 207-216
-
-
Williams, D.P.1
Pirmohamed, M.2
Naisbitt, D.J.3
Uetrecht, J.P.4
Park, B.K.5
-
6
-
-
33644755515
-
Rechallenge with clozapine following leucopenia or neutropenia during previous therapy
-
Dunk LR, Annan LJ, Andrews CD. Rechallenge with clozapine following leucopenia or neutropenia during previous therapy. Br J Psychiatry 2006; 188: 255-63.
-
(2006)
Br J Psychiatry
, vol.188
, pp. 255-263
-
-
Dunk, L.R.1
Annan, L.J.2
Andrews, C.D.3
-
7
-
-
38649101300
-
Haematological toxicity of drugs used in psychiatry
-
Flanagan RJ, Dunk L. Haematological toxicity of drugs used in psychiatry. Hum Psychopharmacol 2008; 23 Suppl 1: 27-41.
-
(2008)
Hum Psychopharmacol
, vol.23
, pp. 27-41
-
-
Flanagan, R.J.1
Dunk, L.2
-
8
-
-
32544438807
-
In vitro toxicity of clozapine, olanzapine, and quetiapine on granulocyte-macrophage progenitors (GM-CFU)
-
Pessina A, Turlizzi E, Bonomi A, Guizzardi F, Cavicchini L, Croera C, et al. In vitro toxicity of clozapine, olanzapine, and quetiapine on granulocyte-macrophage progenitors (GM-CFU). Pharmacopsychiatry 2006; 39: 20-2.
-
(2006)
Pharmacopsychiatry
, vol.39
, pp. 20-22
-
-
Pessina, A.1
Turlizzi, E.2
Bonomi, A.3
Guizzardi, F.4
Cavicchini, L.5
Croera, C.6
|